Cargando…
Immune thrombocytopenia: improving quality of life and patient outcomes
Immune thrombocytopenia (ITP) is an immune-mediated disorder characterized by a reduced platelet count and patients may develop bruising or mucosal bleeding. Since 2003, generic health-related quality of life (HRQoL) measures have been applied and ITP-specific measures developed, alongside trials of...
Autores principales: | Trotter, Patrick, Hill, Quentin A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267629/ https://www.ncbi.nlm.nih.gov/pubmed/30568522 http://dx.doi.org/10.2147/PROM.S140932 |
Ejemplares similares
-
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
por: Viana, Ricardo, et al.
Publicado: (2021) -
PB2685: QUALITY OF LIFE IN INDIAN ADULTS WITH IMMUNE THROMBOCYTOPENIA
por: Bhat, Vivek, et al.
Publicado: (2023) -
Reliability and validity of the Amharic version of immune thrombocytopenia life quality index tool for assessment of the health-related quality of life in Ethiopian patients of immune thrombocytopenia: Cross-sectional study
por: Beyene, Dessale Abate, et al.
Publicado: (2023) -
Health-related quality of life in children with chronic immune thrombocytopenia in China
por: Zhang, Heng, et al.
Publicado: (2016) -
Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia
por: Boccia, Ralph, et al.
Publicado: (2020)